The online version of this article (https://doi.org/10.1007/s11102-017-0850-6) contains supplementary material, which is available to authorized users.
Mutation frequencies of PROP1, POU1F1 and HESX1 in patients with combined pituitary hormone deficiencies (CPHD) vary substantially between populations. They are low in sporadic CPHD patients in Western Europe. However, most clinicians still routinely send DNA of their CPHD patients for genetic screening of these pituitary transcription factors. Before we can recommend against screening of PROP1, POU1F1 and HESX1 as part of routine work-up for Western-European sporadic CPHD patients, it is crucial to rule out possible defects in regulatory regions of these genes, which could also disturb the complex process of pituitary organogenesis.
The regulatory regions of PROP1, POU1F1 and HESX1 are not covered by Whole Exome Sequencing as they are largely located outside the coding regions. Therefore, we manually sequenced the regulatory regions, previously defined in the literature, of PROP1, POU1F1 and HESX1 among 88 Dutch patients with CPHD. We studied promoter SNPs in relation to phenotypic data.
We found six known SNPs in the PROP1 promoter. In the POU1F1 promoter, we found one new variant and two known SNPs. We did not find any variant in the HESX1 promoter.
Although the new POU1F1 variant might explain the phenotype of one patient, the general conclusion of this study is that variants in regulatory regions of PROP1, POU1F1 and HESX1 are rare in patients with sporadic CPHD in the Netherlands. We recommend that genetic screening of these pituitary transcription factors should no longer be part of routine work-up for Western-European, and especially Dutch, sporadic CPHD patients.
Supplementary material 1 (DOCX 70 KB)11102_2017_850_MOESM1_ESM.docx
Pfäffle R, Klammt J (2011) Pituitary transcription factors in the aetiology of combined pituitary hormone deficiency. Rev Best Pract Res Clin Endocrinol Metab 25(1):43–60 CrossRef
de Moraes DC, Vaisman M, Conceição FL, Ortiga-Carvalho TM (2012) Pituitary development: a complex, temporal regulated process dependent on specific transcriptional factors. Rev J Endocrinol 215(2):239–245 CrossRef
Kelberman D, Rizzoti K, Lovell-Badge R, Robinson I, Dattani M (2009) Genetic regulation of pituitary gland development in human and mouse. Endocrinol Rev 30(7):790–829 CrossRef
Kim SS, Kim Y, Shin YL, Kim GH, Kim TU, Yoo HW (2003) Clinical characteristics and molecular analysis of PIT1. PROP1, LHX3, and HESX1 in combined pituitary hormone deficiency patients with abnormal pituitary MR imaging. Horm Res 60:277–283 PubMed
McLennan K, Jeske Y, Cotterill A et al (2003) Combined pituitary hormone deficiency in Australian children: clinical and genetic correlates. Clin Endocrinol (Oxf) 58:785–794 CrossRef
Rainbow LA, Rees SA, Shaikh MG et al (2005) Mutation analysis of POUF-1, PROP-1 and HESX-1 show low frequency of mutations in children with sporadic forms of combined pituitary hormone deficiency and septo-optic dysplasia. Clin Endocrinol (Oxf) 62:163–168 CrossRef
Lemos MC, Gomes L, Bastos M et al (2006) PROP1 gene analysis in Portuguese patients with combined pituitary hormone deficiency. Clin Endocrinol (Oxf) 65:479–485 CrossRef
Dateki S, Fukami M, Uematsu A, Kaji M, Iso M, Ono M, Mizota M, Yokoya S, Motomura K, Kinoshita E, Moriuchi H, Ogata T (2010) Mutation and gene copy number analyses of six pituitary transcription factor genes in 71 patients with combined pituitary hormone deficiency: identification of a single patient with LHX4 deletion. J Clin Endocrinol Metab 95(8):4043–4047 CrossRefPubMed
Fritez N, Sobrier ML, Iraqi H, Vié-Luton MP, Netchine I, El Annas A, Pantel J, Collot N, Rose S, Piterboth W, Legendre M, Chraibi A, Amselem S, Kadiri A, Hilal L (2015) Molecular screening of a large cohort of Moroccan patients with congenital hypopituitarism. Clin Endocrinol (Oxf) 82(6):876–884 CrossRef
Baş F, Uyguner ZO, Darendeliler F, Aycan Z, Çetinkaya E, Berberoğlu M, Şiklar Z, Öcal G, Darcan Ş, Gökşen D, Topaloğlu AK, Yüksel B, Özbek MN, Ercan O, Evliyaoğlu O, Çetinkaya S, Şen Y, Atabek E, Toksoy G, Aydin BK, Bundak R (2015) Molecular analysis of PROP1, POU1F1, LHX3, and HESX1 in Turkish patients with combined pituitary hormone deficiency: a multicenter study. Endocrine 49(2):479–491 CrossRefPubMed
Del Blanco DG, de Graaff LC, Visser TJ, Hokken-Koelega AC (2013) Single nucleotide variants in two Hedgehog genes, SHH and HHIP, as genetic cause of combined pituitary hormone deficiency. Clin Endocrinol (Oxf) 78(3):415–423 CrossRef
Gorbenko Del Blanco D, Romero CJ, Diaczok D, de Graaff LC, Radovick S, Hokken-Koelega AC (2012) A novel OTX2 mutation in a patient with combined pituitary hormone deficiency, pituitary malformation and an underdeveloped left optic nerve. Eur J Endocrinol 167(3):441–452 CrossRef
de Graaff LC, Argente J, Veenma DC, Drent ML, Uitterlinden AG, Hokken-Koelega AC (2010) PROP1, HESX1, POU1F1, LHX3 and LHX4 mutation and deletion screening and GH1 P89L and IVS3 + 1/+2 mutation screening in a Dutch nationwide cohort of patients with combined pituitary hormone deficiency. Horm Res Paediatr 73(5):363–371 CrossRefPubMed
de Graaff LC, Argente J, van Meurs JB, Uitterlinden AG, Hokken-Koelega AC (2010) Genetic polymorphisms in the locus control region and promoter of GH1 are related to serum IGF-I levels and height in patients with isolated growth hormone deficiency and healthy controls. Horm Res Paediatr 73(1):25–34 CrossRefPubMed
de Graaff LC, Argente J, Veenma DC, Herrebout MA, Friesema EC, Uitterlinden AG, Drent ML, Campos-Barros A, Hokken-Koelega AC (2009) Genetic screening of a Dutch population with isolated GH deficiency (IGHD). Clin Endocrinol (Oxf) 70(5):742–750 CrossRef
Gorbenko Del Blanco D, de Graaff LC, Posthouwer D, Visser TJ, Hokken-Koelega AC (2011) Isolated GH deficiency: mutation screening and copy number analysis of HMGA2 and CDK6 genes. Eur J Endocrinol 165(4):537–544 CrossRef
Dusatkova P, Pfäffle R, Brown MR, Akulevich N, Arnhold IJ, Kalina MA, Kot K, Krzisnik C, Lemos MC, Malikova J, Navardauskaite R, Obermannova B, Pribilincova Z, Sallai A, Stipancic G, Verkauskiene R, Cinek O, Blum WF, Parks JS, Austerlitz F, Lebl J (2016) Genesis of two most prevalent PROP1 gene variants causing combined pituitary hormone deficiency in 21 populations. Eur J Hum Genet 24(3):415–420 CrossRefPubMed
De Rienzo F, Mellone S, Bellone S, Babu D, Fusco I, Prodam F, Petri A, Muniswamy R, De Luca F, Salerno M, Momigliano-Richardi P, Bona G, Giordano M, Italian Study Group on Genetics of CPHD (2015) Frequency of genetic defects in combined pituitary hormone deficiency: a systematic review and analysis of a multicentre Italian cohort. Clin Endocrinol (Oxf) 83(6):849–860 CrossRef
- Genetic screening of regulatory regions of pituitary transcription factors in patients with idiopathic pituitary hormone deficiencies
Anita C. S. Hokken-Koelega
Robin P. Peeters
Theo J. Visser
Laura C. G. de Graaff
- Springer US
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
e.Med Kampagnen-Visual, Mail Icon II